The FDA has approved the Premarket Approval application for ReActiv8 (Mainstay Medical), an implantable neurostimulation system indicated to treat low back pain (LBP).
JUNE 23, 2020
JUNE 23, 2020
The FDA has approved the Premarket Approval application for ReActiv8 (Mainstay Medical), an implantable neurostimulation system indicated to treat low back pain (LBP).